MyCare InsitePsychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is…John BuckleyJuly 8, 2020
MyCare InsitePsychiatry News HLS Therapeutics to Become Distributor of the Saladax MyCare™ Psychiatry Line including the Insite Point-of-Care Device and Antipsychotic Reagents The MyCare Insite is a point-of-care (POC) device that uses just a single drop of…John BuckleyJune 27, 2020
MyCare InsitePsychiatry News Saladax Biomedical launches clozapine test in the US after FDA grants market authorization Saladax is advancing personalized medicine by providing psychiatrists with the first commercially available antipsychotic test…John BuckleyMay 1, 2020
MyCare InsitePsychiatry News Studies Feature Clinical Validations of Clozapine Point of Care Testing Using a Single Drop of Blood to Aid Psychiatrists in Better Treatment of Patients With Schizophrenia View the original press release at businesswire.com Bethlehem, PA – October 24, 2019 –Saladax Biomedical,…John BuckleyOctober 24, 2019
MyCare InsitePsychiatry News Saladax Develops First-Ever Rapid Test for an Antipsychotic Drug Using a Single Drop of Blood to Aid Psychiatrists in the Treatment of Schizophrenia Bethlehem, PA – September 05, 2019 –Saladax Biomedical today announced that its MyCare Insite Clozapine Test…John BuckleySeptember 5, 2019